AMNEAL PHARMACEUTICALS, INC., 8-K/A filed on 11/12/2024
Amended Current report filing
v3.24.3
Document and Entity Information Document
Nov. 08, 2024
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Document Period End Date Nov. 08, 2024
Entity Registrant Name AMNEAL PHARMACEUTICALS, INC.
Entity Central Index Key 0001723128
Entity Emerging Growth Company false
Entity File Number 001-38485
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 93-4225266
Entity Address, Address Line One 400 Crossing Blvd
Entity Address, City or Town Bridgewater
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08807
City Area Code 908
Local Phone Number 947-3120
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock, par value $0.01 per share
Trading Symbol AMRX
Security Exchange Name NASDAQ
Amendment Description This Amendment No.1 to the Current Report on Form 8-K filed by Amneal Pharmaceuticals, Inc. on November 8, 2024 (the "Original Report") is being filed solely for the purpose of including the missing Inline XBRL on the cover page that was inadvertently excluded from the Original Report. No other changes have been made to the original filing.